Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002)

Diagnostic Microbiology and Infectious Disease

Volumn 50, Issue 1, 2004, Pages 59-69

  Biedenbach, Douglas J ^a   Moet, Gary J ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Resistance; SENTRY

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EUROPE; GEOGRAPHY; GRAM NEGATIVE BACTERIUM; HEALTH CENTER; HEALTH PROGRAM; HOSPITAL INFECTION; INTENSIVE CARE UNIT; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NORTH AMERICA; PATIENT MONITORING; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD-BORNE PATHOGENS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; INFANT, NEWBORN; LATIN AMERICA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NORTH AMERICA; POPULATION SURVEILLANCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 5444226347     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.05.003     Document Type: Article

References (30)

1. Beekmann S.E., Diekema D.J., Chapin K.C., Doern G.V. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol. 41:2003;3119-3125
2. Collin B.A., Leather H., Wingard J.R., Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis. 33:2001;947-953
3. Christensen J.E., Stencil J.A., Reed K.D. Rapid identification of bacteria from positive blood cultures by terminal restriction fragment length polymorphism profile analysis of the 16S rRNA gene. J Clin Microbiol. 41:2003;3790-3800
4. Crnich C.J., Maki D.G. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis. 34:2002;1362-1368
5. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Kugler K.C., Beach M.L., Sader H.S. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents. 13:1999;257-271
6. Diekema D.J., Pfaller M.A., Jones R.N. SENTRY Participant Group. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America SENTRY Antimicrobial Surveillance Program, 1997-2000. Int J Antimicrob Agents. 20:2002;412-418
7. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, The SENTRY Participants Group (2001). Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32, S114
8. Diekema D.J., Pfaller M.A., Turnidge J., Verhoef J., Bell J., Fluit A.C., Doern G.V., Jones R.N. SENTRY Participants Group. Genetic relatedness of multidrug-resistant, methicillin (oxacillin) resistant Staphylococcus aureus bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998. Microbiol Drug Resist. 6:2000;213-221
9. Karchmer A.W. Nosocomial bloodstream infections Organisms, risk factors, and implications. Clin Infect Dis. 31:2000;S139-S143
10. Leibovici L. Bacteraemia in the very old. Features and treatment Drugs Aging. 6:1995;456-464
11. Leibovici L., Berger R., Gruenewald T., Yahav J., Yehezkelli Y., Milo G., Paul M., Samra Z., Pitlik S.D. Departmental consumption of antibiotic drugs and subsequent resistance A quantitative link. J Antimicrob Chemother. 48:2001;535-540
12. Luzzaro F., Vigano E.F., Fossati D., Grossi A., Sala A., Sturla C., Saudelli M., Toniolo A. AMCLI Lombardia Hospital Infectious Study Group. Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy A two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis. 21:2002;849-855
13. McDougal L.K., Steward C.D., Killgore G.E., Chaitram J.M., McAllister S.K., Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States Establishing a national database. J Clin Microbiol. 41:2003;5113-5120
14. Munson E.L., Diekema D.J., Beekmann S.E., Chapin K.C., Doern G.V. Detection and treatment of bloodstream infection Laboratory reporting and antimicrobial management. J Clin Microbiol. 41:2003;495-497
15. Mutnick A.H., Kirby J.T., Jones R.N. CANCER Study Group. CANCER resistance surveillance program Initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance. Ann Pharmacother. 37:2003;47-56
16. Mylotte J.M., Tayara A., Goodnough S. Epidemiology of bloodstream infection in nursing home residents Evaluation in a large cohort from multiple homes. Clin Infect Dis. 35:2002;1484
17. National Committee for Clinical Laboratory Standards (2003a). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, sixth edition: Approved standard M7-A6. NCCLS, Wayne, PA
18. National Committee for Clinical Laboratory Standards (2003b). Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S13. NCCLS, Wayne, PA
19. Papanicolaou G.A., Meyers B.R., Meyers J., Mendelson M.H., Lou W., Emre S., Sheiner P., Miller C. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients Risk factors for acquisition and mortality. Clin Infect Dis. 23:1996;760-766
20. Pfaller M.A., Jones R.N., Doern G.V., Kugler K. The SENTRY Participants Group. Bacterial pathogens isolated from patients with bloodstream infection Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother. 42:1998;1762-1770
21. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., Beach M.L. The SENTRY Participants Group. Survey of bloodstream infections attributable to Gram-positive cocci Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 33:1999;283-297
22. Pfaller M.A., Acar J., Jones R.N., Verhoef J., Turnidge J., Sader H.S. Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program. Clin Infect Dis. 32:2001;S156-S167
23. Sader H.S., Pfaller M.A., Jones R.N., Doern G.V., Gales A.C., Winokur P.L., Kugler K.C. Bacterial pathogens isolated from patients with bloodstream infections in Latin America, 1997 Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program. Brazil J Infect Dis. 3:1999;97-110
24. Sahm D.F., Marsilio M.K., Piazza G. Antimicrobial resistance in key bloodstream bacterial solates Electronic surveillance with the Surveillance Network Database: USA. Clin Infect Dis. 29:1999;259-263
25. Stefani S., Varaldo P.E. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect. 9:2003;1179-1186
26. Velasco E., Byington R., Martins C.A., Schirmer M., Dias L.M., Goncalves V.M. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center. Eur J Clin Microbiol Infect Dis. 22:2003;137-143
27. Warren D.K., Zack J.E., Elward A.M., Cox M.J., Fraser V.J. Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: A 21-month prospective study. Clin Infect Dis. 33:2001;1329
28. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., Reller L.B. The clinical significance of positive blood cultures in the 1990s A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 24:1997;584-602
29. Wisplinghoff H., Seifert H., Tallent S.M., Bischoff T., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in pediatric patients in United States hospitals Epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J. 22:2003;686-691
30. Zaragoza R., Artero A., Camarena J.J., Sancho S., Gonzalez R., Nogueira J.M. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 9:2003;412-418